Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Alignment Healthcare Inc’s stock clocked out at $13.16, down -1.72% from its previous closing price of $13.39. In other words, the price has decreased by -$1.72 from its previous closing price. On the day, 2.24 million shares were traded.
Ratios:
To gain a deeper understanding of ALHC’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.92 whereas as Long-Term Debt/Eq ratio is at 1.91.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on December 03, 2024, Upgraded its rating to Overweight and sets its target price to $17 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on May 30, 2024, whereas the target price for the stock was revised from $7.75 to $11.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 18 ’25 when Maroney Dawn Christine sold 30,000 shares for $13.72 per share. The transaction valued at 411,471 led to the insider holds 1,576,097 shares of the business.
Wagner Andreas P. sold 14,878 shares of ALHC for $213,946 on Feb 12 ’25. The Chief Human Resources Officer now owns 200,885 shares after completing the transaction at $14.38 per share. On Feb 11 ’25, another insider, KAO JOHN E, who serves as the Chief Executive Officer of the company, sold 90,000 shares for $14.23 each. As a result, the insider received 1,280,304 and left with 2,183,100 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.02 while its Price-to-Book (P/B) ratio in mrq is 22.01.
Stock Price History:
Over the past 52 weeks, ALHC has reached a high of $15.82, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is -0.31%, while the 200-Day Moving Average is calculated to be 23.16%.
Shares Statistics:
A total of 191.60M shares are outstanding, with a floating share count of 109.78M. Insiders hold about 42.73% of the company’s shares, while institutions hold 56.51% stake in the company.
Earnings Estimates
The dynamic stock of Alignment Healthcare Inc (ALHC) is currently being evaluated by a team of 5.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.28 and -$0.29 for the fiscal current year, implying an average EPS of -$0.29. EPS for the following year is -$0.09, with 5.0 analysts recommending between -$0.02 and -$0.15.
Revenue Estimates
In the current quarter, 10 analysts expect revenue to total $677.42M. It ranges from a high estimate of $693.01M to a low estimate of $668.2M. As of the current estimate, Alignment Healthcare Inc’s year-ago sales were $465.39MFor the next quarter, 10 analysts are estimating revenue of $854.69M. There is a high estimate of $927.88M for the next quarter, whereas the lowest estimate is $812.95M.
A total of 11 analysts have provided revenue estimates for ALHC’s current fiscal year. The highest revenue estimate was $2.7B, while the lowest revenue estimate was $2.67B, resulting in an average revenue estimate of $2.68B. In the same quarter a year ago, actual revenue was $1.82BBased on 11 analysts’ estimates, the company’s revenue will be $3.48B in the next fiscal year. The high estimate is $3.7B and the low estimate is $3.37B.
